Market Overview:
The global mesna (mesnex) market is expected to register a CAGR of 5.8% during the forecast period, 2018-2030. The market growth can be attributed to the increasing incidence of bladder cancer and rising demand for effective and safe treatments. Based on type, the global mesna (mesnex) market is segmented into oral and injections. The oral segment is anticipated to account for a larger share in terms of revenue, owing to its ease of use and growing preference among patients. However, the injections segment is projected to grow at a higher CAGR during the forecast period due to its better efficacy as compared with oral administration. On the basis of application, hospital pharmacies accounted for majority share in 2017; however, retail pharmacies are expected witness highest growth rate over the forecast period owing growing demand from consumers across developed countries such as U.S.
Product Definition:
Mesna (mesnex) is a drug used to prevent or reduce the side effects of cancer chemotherapy drugs that can damage the bladder. Mesna is given by injection into a vein (intravenous) before, during, and after receiving the chemotherapeutic agent.
Oral:
Oral is a form of drug delivery which involves the administration of drugs in the form of tablets or capsules. It is also used to deliver vaccines and other liquids, usually via a prescription from a doctor. The most common route for oral drug delivery is through the mouth; it can be administered by self-administration or with help from healthcare professionals.
The factors that propel growth include increasing geriatric population base, rising prevalence of chronic diseases such as cancer.
Injections:
Injections are the most common way of medication used in patients suffering from sleep apnea. The injections allow for a continuous supply of medicine to the patient without them having to consume it orally. In addition, they help in reducing side effects caused due to drug metabolism by liver and kidneys.
Application Insights:
The market is segmented by application into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacy segment dominated the market in 2017 owing to the growing prevalence of cancer and other life-threatening diseases that require immediate medical attention. Moreover, increasing government funding for clinical research that ultimately results in product approvals by regulatory authorities such as U.S. FDA further boost the demand for mesna over other drugs with similar mechanism of action or efficacy.
The online pharmacy segment is expected to witness lucrative growth during the forecast period due to various factors such as availability of 24/7 customer support services via e-mail and website; easy payment options available including credit card, debit cards,.
Regional Analysis:
North America dominated the global mesna market in 2017. The presence of a large number of manufacturers coupled with high R&D expenditure by companies is expected to drive the demand for mesnex during the forecast period. In addition, increasing incidence of osteoarthritis and growing geriatric population are also expected to propel market growth over the coming years.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising disposable income, improving healthcare infrastructure and an increase in awareness about advanced treatment options for joint diseases such as osteoarthritis.
Growth Factors:
- Increasing incidence of bladder cancer: The incidence of bladder cancer is increasing globally. This will drive the demand for mesna in the coming years.
- Growing awareness about mesna: There is growing awareness among physicians and patients about the benefits of mesna therapy, which is likely to boost the demand for this drug in the near future.
- Rising number of clinical studies on mesna: A large number of clinical studies are being conducted on mesna across the world, which is likely to increase its adoption in the coming years.
- Launch of new products: Several pharmaceutical companies are expected to launch new products containing mesna in the near future, thereby propelling growth within this market during forecast period 2017-2025
Scope Of The Report
Report Attributes
Report Details
Report Title
Mesna (Mesnex) Market Research Report
By Type
Oral, Injections
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Companies
Mylan, Baxter, Teva Pharmaceutical, Fresenius Kabi, Hikma Pharmaceuticals, Gland Pharma Limited, Sagent Pharmaceuticals, Athenex Pharmaceuticals, Jiangsu Hengrui Medicine
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
241
Number of Tables & Figures
169
Customization Available
Yes, the report can be customized as per your need.
Global Mesna (Mesnex) Market Report Segments:
The global Mesna (Mesnex) market is segmented on the basis of:
Types
Oral, Injections
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Mylan
- Baxter
- Teva Pharmaceutical
- Fresenius Kabi
- Hikma Pharmaceuticals
- Gland Pharma Limited
- Sagent Pharmaceuticals
- Athenex Pharmaceuticals
- Jiangsu Hengrui Medicine
Highlights of The Mesna (Mesnex) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral
- Injections
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Mesna (Mesnex) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Mesna is a medication used to treat infections. It is also used to prevent or reduce the severity of pain after surgery.
Some of the key players operating in the mesna (mesnex) market are Mylan, Baxter, Teva Pharmaceutical, Fresenius Kabi, Hikma Pharmaceuticals, Gland Pharma Limited, Sagent Pharmaceuticals, Athenex Pharmaceuticals, Jiangsu Hengrui Medicine.
The mesna (mesnex) market is expected to grow at a compound annual growth rate of 5.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Mesna (Mesnex) Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Mesna (Mesnex) Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Mesna (Mesnex) Market - Supply Chain
4.5. Global Mesna (Mesnex) Market Forecast
4.5.1. Mesna (Mesnex) Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Mesna (Mesnex) Market Size (000 Units) and Y-o-Y Growth
4.5.3. Mesna (Mesnex) Market Absolute $ Opportunity
5. Global Mesna (Mesnex) Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Mesna (Mesnex) Market Size and Volume Forecast by Type
5.3.1. Oral
5.3.2. Injections
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Mesna (Mesnex) Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Mesna (Mesnex) Market Size and Volume Forecast by Application
6.3.1. Hospital Pharmacies
6.3.2. Retail Pharmacies
6.3.3. Online Pharmacies
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Mesna (Mesnex) Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Mesna (Mesnex) Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Mesna (Mesnex) Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Mesna (Mesnex) Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Mesna (Mesnex) Demand Share Forecast, 2019-2026
9. North America Mesna (Mesnex) Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Mesna (Mesnex) Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Mesna (Mesnex) Market Size and Volume Forecast by Application
9.4.1. Hospital Pharmacies
9.4.2. Retail Pharmacies
9.4.3. Online Pharmacies
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Mesna (Mesnex) Market Size and Volume Forecast by Type
9.7.1. Oral
9.7.2. Injections
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Mesna (Mesnex) Demand Share Forecast, 2019-2026
10. Latin America Mesna (Mesnex) Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Mesna (Mesnex) Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Mesna (Mesnex) Market Size and Volume Forecast by Application
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Online Pharmacies
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Mesna (Mesnex) Market Size and Volume Forecast by Type
10.7.1. Oral
10.7.2. Injections
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Mesna (Mesnex) Demand Share Forecast, 2019-2026
11. Europe Mesna (Mesnex) Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Mesna (Mesnex) Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Mesna (Mesnex) Market Size and Volume Forecast by Application
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Online Pharmacies
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Mesna (Mesnex) Market Size and Volume Forecast by Type
11.7.1. Oral
11.7.2. Injections
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Mesna (Mesnex) Demand Share, 2019-2026
12. Asia Pacific Mesna (Mesnex) Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Mesna (Mesnex) Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Mesna (Mesnex) Market Size and Volume Forecast by Application
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Online Pharmacies
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Mesna (Mesnex) Market Size and Volume Forecast by Type
12.7.1. Oral
12.7.2. Injections
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Mesna (Mesnex) Demand Share, 2019-2026
13. Middle East & Africa Mesna (Mesnex) Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Mesna (Mesnex) Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Mesna (Mesnex) Market Size and Volume Forecast by Application
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Online Pharmacies
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Mesna (Mesnex) Market Size and Volume Forecast by Type
13.7.1. Oral
13.7.2. Injections
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Mesna (Mesnex) Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Mesna (Mesnex) Market: Market Share Analysis
14.2. Mesna (Mesnex) Distributors and Customers
14.3. Mesna (Mesnex) Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Mylan
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Baxter
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Teva Pharmaceutical
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Fresenius Kabi
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Hikma Pharmaceuticals
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Gland Pharma Limited
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Sagent Pharmaceuticals
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Athenex Pharmaceuticals
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Jiangsu Hengrui Medicine
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook